A detailed history of Ascent Group, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Ascent Group, LLC holds 8,096 shares of TMO stock, worth $4.65 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
8,096
Previous 11,029 26.59%
Holding current value
$4.65 Million
Previous $6.1 Million 17.9%
% of portfolio
0.39%
Previous 0.5%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$531.86 - $624.21 $1.56 Million - $1.83 Million
-2,933 Reduced 26.59%
8,096 $5.01 Million
Q2 2024

Aug 14, 2024

BUY
$541.52 - $599.02 $303,792 - $336,050
561 Added 5.36%
11,029 $6.1 Million
Q1 2024

May 15, 2024

BUY
$528.82 - $599.43 $1.84 Million - $2.09 Million
3,484 Added 49.89%
10,468 $6.08 Million
Q4 2023

Feb 13, 2024

BUY
$431.41 - $532.94 $10,353 - $12,790
24 Added 0.34%
6,984 $3.71 Million
Q3 2023

Nov 14, 2023

SELL
$498.29 - $574.41 $55,310 - $63,759
-111 Reduced 1.57%
6,960 $3.52 Million
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $396,090 - $460,490
-779 Reduced 9.92%
7,071 $3.69 Million
Q1 2023

May 10, 2023

SELL
$535.0 - $604.82 $468,660 - $529,822
-876 Reduced 10.04%
7,850 $4.52 Million
Q4 2022

Feb 16, 2023

BUY
$484.71 - $571.37 $256,896 - $302,826
530 Added 6.47%
8,726 $4.81 Million
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $58,326 - $69,516
115 Added 1.42%
8,196 $4.21 Million
Q2 2022

Aug 05, 2022

BUY
$500.9 - $612.21 $215,887 - $263,862
431 Added 5.63%
8,081 $4.84 Million
Q1 2022

May 10, 2022

SELL
$524.0 - $644.92 $12,052 - $14,833
-23 Reduced 0.3%
7,650 $4.52 Million
Q4 2021

Mar 01, 2022

BUY
$569.0 - $667.24 $4.37 Million - $5.12 Million
7,673 New
7,673 $4.45 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $225B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Ascent Group, LLC Portfolio

Follow Ascent Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.